These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 1629342)
1. Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay. Mitchell LA; Zhang T; Ho M; Décarie D; Tingle AJ; Zrein M; Lacroix M J Clin Microbiol; 1992 Jul; 30(7):1841-7. PubMed ID: 1629342 [TBL] [Abstract][Full Text] [Related]
2. Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals. Mitchell LA; Ho MK; Rogers JE; Tingle AJ; Marusyk RG; Weber JM; Duclos P; Tepper ML; Lacroix M; Zrein M J Clin Microbiol; 1996 Sep; 34(9):2210-8. PubMed ID: 8862587 [TBL] [Abstract][Full Text] [Related]
3. A synthetic peptide ELISA for the screening of rubella virus neutralizing antibodies in order to ascertain immunity. Giessauf A; Letschka T; Walder G; Dierich MP; Würzner R J Immunol Methods; 2004 Apr; 287(1-2):1-11. PubMed ID: 15099751 [TBL] [Abstract][Full Text] [Related]
4. Rubella virus vaccine associated arthropathy in postpartum immunized women: influence of preimmunization serologic status on development of joint manifestations. Mitchell LA; Tingle AJ; Grace M; Middleton P; Chalmers AC J Rheumatol; 2000 Feb; 27(2):418-23. PubMed ID: 10685808 [TBL] [Abstract][Full Text] [Related]
5. Selective tolerance to the E1 protein of rubella virus in congenital rubella syndrome. Mauracher CA; Mitchell LA; Tingle AJ J Immunol; 1993 Aug; 151(4):2041-9. PubMed ID: 8345195 [TBL] [Abstract][Full Text] [Related]
6. An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain. Wolinsky JS; Sukholutsky E; Moore WT; Lovett A; McCarthy M; Adame B J Virol; 1993 Feb; 67(2):961-8. PubMed ID: 7678312 [TBL] [Abstract][Full Text] [Related]
7. Differential antibody responses to rubella virus infection in males and females. Mitchell LA; Zhang T; Tingle AJ J Infect Dis; 1992 Dec; 166(6):1258-65. PubMed ID: 1431244 [TBL] [Abstract][Full Text] [Related]
8. Persistence of vaccine-induced immune responses to rubella: comparison with natural infection. Horstmann DM; Schluederberg A; Emmons JE; Evans BK; Randolph MF; Andiman WA Rev Infect Dis; 1985; 7 Suppl 1():S80-5. PubMed ID: 4001740 [TBL] [Abstract][Full Text] [Related]
9. Immune responses to wild and vaccine rubella viruses after rubella vaccination. Cusi MG; Metelli R; Valensin PE Arch Virol; 1989; 106(1-2):63-72. PubMed ID: 2764728 [TBL] [Abstract][Full Text] [Related]
10. Sex differences in antibody- and cell-mediated immune response to rubella re-immunisation. Mitchell LA J Med Microbiol; 1999 Dec; 48(12):1075-1080. PubMed ID: 10591160 [TBL] [Abstract][Full Text] [Related]
11. Immunoblot analysis of natural and vaccine-induced IgG responses to rubella virus proteins expressed in insect cells. Nedeljkovic J; Jovanovic T; Mladjenovic S; Hedman K; Peitsaro N; Oker-Blom C J Clin Virol; 1999 Oct; 14(2):119-31. PubMed ID: 10588454 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the performance and reproducibility of various serological methods and diagnostic kits for the detection of rubella antibodies. Enders G; Knotek F J Virol Methods; 1985 May; 11(1):1-14. PubMed ID: 3891766 [TBL] [Abstract][Full Text] [Related]
13. Comparison of a whole-virus enzyme immunoassay (EIA) with a peptide-based EIA for detecting rubella virus immunoglobulin G antibodies following rubella vaccination. Zrein M; Joncas JH; Pedneault L; Robillard L; Dwyer RJ; Lacroix M J Clin Microbiol; 1993 Jun; 31(6):1521-4. PubMed ID: 8314994 [TBL] [Abstract][Full Text] [Related]
14. Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals. Schluederberg A; Horstmann DM; Andiman WA; Randolph MF J Infect Dis; 1978 Dec; 138(6):877-83. PubMed ID: 105058 [TBL] [Abstract][Full Text] [Related]
15. Failed rubella immunization in adults: association with immunologic and virological abnormalities. Tingle AJ; Chantler JK; Kettyls GD; Larke RP; Schulzer M J Infect Dis; 1985 Feb; 151(2):330-6. PubMed ID: 3968452 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of antibodies against a rubella virus neutralizing domain for determination of immune status. Cordoba P; Lanoel A; Grutadauria S; Zapata M Clin Diagn Lab Immunol; 2000 Nov; 7(6):964-6. PubMed ID: 11063507 [TBL] [Abstract][Full Text] [Related]
17. The development of an M antibody capture ELISA for rubella IgM. Bellamy K; Rousseau SA; Gardner PS J Virol Methods; 1986 Nov; 14(3-4):243-51. PubMed ID: 3539958 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the latex agglutination test with the hemagglutination inhibition test, enzyme-linked immunosorbent assay, and neutralization test for detection of antibodies to rubella virus. Meegan JM; Evans BK; Horstmann DM J Clin Microbiol; 1982 Oct; 16(4):644-9. PubMed ID: 7153314 [TBL] [Abstract][Full Text] [Related]
19. A novel cell-based high throughput assay to determine neutralizing antibody titers against circulating strains of rubella virus. Kanbayashi D; Kurata T; Takahashi K; Kase T; Komano J J Virol Methods; 2018 Feb; 252():86-93. PubMed ID: 29191395 [TBL] [Abstract][Full Text] [Related]
20. Detection of immunoglobulin G and A antibodies to rubella virus in urine and antibody responses to vaccine-induced infection. Takahashi S; Machikawa F; Noda A; Oda T; Tachikawa T Clin Diagn Lab Immunol; 1998 Jan; 5(1):24-7. PubMed ID: 9455874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]